Whether you're interested in injectable options or exploring weight loss medication online for the first time, Klinic is here to support you every step of the way
Among these, the PCT application WO2021155841A1 (filed on February 5, 2021, and published on August 12, 2021) has been granted in the US, China, and Europe
Oral Treatment Option Semaglutide Rybelsus (oral semaglutide) is FDA-approved
Key ingredient Tranexamic Acid (1,000ppm) works to inhibit melanin production and reduce pigmentation around the delicate eye area, paired with Glutathione (1,000ppm) to block melanin formation and eliminate activated oxygen that causes discoloration
For patients with a diagnosed Vitamin B12 deficiency, our medical team typically recommends an initial loading phase, which may involve daily injections or several injections per week over the first one to two weeks